Statistics
Publications
8
Citations
428
H-Index
8
Active since
2012
Affiliations
Wanke Zhao is an author at University of Oklahoma Health Sciences Center specializing in jak2 v617f mutation, myeloproliferative neoplasms, and jak2 mutations.
Publications per year
2012–2020
8
8
Phenotype risk scores identify patients with unrecognized Mendelian disease patterns
Lisa Bastarache, Jacob Hughey, Scott J. Hebbring et al. · Science · 2018 · 239 citations
Efficacy of ALK5 inhibition in myelofibrosis
Lanzhu Yue, Matthias Bartenstein, Wanke Zhao et al. · JCI Insight · 2017 · 48 citations · Full text
Identification of an orally available compound with potent and broad FLT3 inhibition activity
Ye Chen, Yingjie Guo, Wanke Zhao et al. · Oncogene · 2015 · 27 citations
1–5 of 8